Circular Genomics leverages circular RNA for the diagnosis and treatment of psychiatric and neurological disorders. The company is a self-described pioneer in precision medicine for mental health.

Circular Genomics

Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions

Read about how we’re making precision psychiatry a reality with our novel circular RNA-based blood test that can predict patients’ responses to SSRIs. Follow us to be among the first to know when MindLight Antidepressant Response Test™ comes to market!  

#precisionpsychiatry #majordepressivedisorder #mentalhealth

The Circular Genomics team is live at Direct Primary Care Summit 2024 in Dallas! Stop by booth 31 and ask us about MindLight™, our circular RNA-based biomarker test for predicting SSRI response launching later this year. This first-of-its-kind antidepressant response test will tell healthcare providers which patients are likely to achieve clinical response to SSRIs, and not just inform them about metabolism or potential drug interactions.

#precisionpsychiatry #antidepressantresponsetest

It’s our last day at Direct Primary Care Summit in Dallas! Visit our booth #31 to learn about Circular Genomics and how we’re using circular RNA-based innovation to drive precision psychiatry. 

Follow us to be amongst the first to know when we launch our inaugural test, the MindLight™ Antidepressant Response Test™!

#precisionpsychiatry #mentalhealth

Follow our new social media pages and subscribe to our newsletter!

With so much excitement and growth, we are pleased to expand our platform to reach a variety of audiences that share our passion for improving the accuracy of diagnosis and treatment of psychiatric and neurological disorders.

Follow us on: 
Facebook at Circular Genomics
Twitter at circgenomics
Instagram at circulargenomics
 
Starting next month, Circular Genomics will be launching its newsletter, The inPsyder where we will be exploring the landscape of mental health and keeping you up to date as we bring precision psychiatry to providers and their patients. Subscribe to The inPsyder at www.circulargenomics.com
 
#CircularGenomics #PrecisionPsychiatry #PrecisionMedicine #MentalHealthInnovation

A great article by David Blivin that highlights our novel approach using circular RNAs as biomarkers for precision medicine in mental healthcare.

#mentalhealth #precisionmedicine

We’re pleased to announce that we will be exhibiting at the Direct Primary Care Summit 2024, June 21-23 in Dallas, Texas! Will you be there? If so, be sure to stop by Booth 31 to learn about Circular Genomics and our soon-to-be-launched circular RNA-based biomarker test for predicting a patient’s response to antidepressants. 

American Academy of Family Physicians American College of Osteopathic Family Physicians Family Medicine Education Consortium - FMEC
#mentalhealth #precisionpsychiatry #precisionmentalhealthcare #dpcsummit2024

COM:CIRCULARGENOMICS

Circular Genomics

name

homepage url

country

linkedin url

employee count

sector

industry

Description

investor of

Metrics